Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 124,961 | 152,069 | 156,234 | 111,014 | 106,275 |
| Cost of Goods | 39,227 | 27,020 | 18,748 | 15,832 | 19,872 |
| Gross Profit | 85,734 | 125,049 | 137,486 | 95,182 | 86,403 |
| Operating Expenses | 110,437 | 368,605 | 98,829 | 86,590 | 169,430 |
| Operating Income | -24,476 | -243,536 | 39,405 | 9,424 | -82,155 |
| Interest Expense | 3,039 | 3,380 | 7,961 | 10,220 | 15,926 |
| Other Income | 5,986 | -7,138 | -278 | 243 | 52,568 |
| Pre-tax Income | -21,529 | -254,054 | 31,166 | -553 | -45,513 |
| Income Tax | 52 | 77,888 | -78,459 | 728 | -17,369 |
| Net Income Continuous | -21,581 | -331,942 | 109,625 | -1,281 | -28,144 |
| Net Income | $-21,581 | $-331,942 | $109,625 | $-1,281 | $-28,144 |
| EPS Basic Total Ops | -0.23 | -4.67 | 2.33 | -0.03 | -1.07 |
| EPS Basic Continuous Ops | -0.23 | -4.67 | 2.33 | -0.03 | -1.07 |
| EPS Diluted Total Ops | -0.23 | -4.67 | 2.03 | -0.03 | -1.07 |
| EPS Diluted Continuous Ops | -0.23 | -4.67 | 2.01 | -0.03 | -1.07 |
| EPS Diluted Before Non-Recurring Items | -0.23 | 0.45 | 2.03 | -0.03 | -1.08 |
| EBITDA(a) | $1,792 | $-214,852 | $73,105 | $38,695 | $-50,044 |